Department of Orthopaedic Surgery, Midwestern University, Downers Grove, Illinois.
Advocate Illinois Masonic Medical Center, Chicago, Illinois.
J Arthroplasty. 2018 Apr;33(4):1052-1056. doi: 10.1016/j.arth.2017.10.054. Epub 2017 Nov 10.
The use of intravenous acetaminophen has seen recent enthusiasm as one component of a multimodal approach to pain management. However, there is a lack of literature examining the efficacy of intravenous acetaminophen for pain control in total joint arthroplasty. The purpose of this study was to evaluate the efficacy of intravenous acetaminophen following primary total knee arthroplasty.
This is a retrospective review of 38 patients undergoing primary total knee arthroplasty by a single surgeon at one institution. Twenty-five patients received 1 gram of intravenous acetaminophen every 6 hours for 24 hours postoperatively. Thirteen patients received no additional intervention. Exclusion criteria were bilateral or concomitant procedures, allergy to medications included in the standard postoperative protocol, neuropathy or sensory disturbances, history of opioid dependence or abuse, deviations from protocol, revision procedures, and incomplete data. Primary outcomes were change in patient-reported visual analog scale (VAS) pain score, overall opioid consumption measured in morphine milligram equivalents, and hospital length of stay.
We found no difference in length of stay, at 3.3 days in the control group and 2.9 days in the intervention group. There was a significant difference in VAS score between 16 and 24 hours. There was a statistically significant decrease in overall opioid consumption in the intravenous acetaminophen group 37.6 vs 18.6 morphine milligram equivalents.
Intravenous acetaminophen is effective in significantly reducing opioid requirements in the first 24 hours following primary total knee arthroplasty. Additionally, there is a clinically significant decrease in VAS pain scores in patients receiving this intervention.
静脉用对乙酰氨基酚作为多模式疼痛管理方法的一个组成部分,近来受到了广泛关注。然而,目前缺乏关于静脉用对乙酰氨基酚在全膝关节置换术疼痛控制中疗效的文献。本研究旨在评估静脉用对乙酰氨基酚在初次全膝关节置换术后的疗效。
这是对一家机构的一位外科医生进行的 38 例初次全膝关节置换术患者的回顾性研究。25 例患者术后每 6 小时接受 1 克静脉用对乙酰氨基酚,持续 24 小时。13 例患者未接受其他干预。排除标准为双侧或同时进行的手术、对标准术后方案中包含的药物过敏、神经病或感觉障碍、阿片类药物依赖或滥用史、偏离方案、翻修手术以及数据不完整。主要结局是患者报告的视觉模拟评分(VAS)疼痛评分变化、以吗啡毫克当量测量的总阿片类药物消耗量以及住院时间。
我们发现住院时间没有差异,对照组为 3.3 天,干预组为 2.9 天。在 16 至 24 小时之间,VAS 评分存在显著差异。在静脉用对乙酰氨基酚组,总阿片类药物消耗量有统计学显著减少(37.6 对 18.6 吗啡毫克当量)。
静脉用对乙酰氨基酚可有效减少初次全膝关节置换术后 24 小时内的阿片类药物需求。此外,接受该干预的患者 VAS 疼痛评分有显著降低。